CAPLIPOINT CAPLIPOINT NIFTY_SMALLNSE
Company Profile ↓Company Overview
CAPLIPOINT (CAPLIPOINT) is a publicly traded company listed on NSE with a market capitalization of ₹20,273.84 Cr. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 17.9%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 18.8%.
Net profit has compounded at 31.6% per year over the last five years.
Revenue has grown at a 24.1% CAGR over the past five years.
Maintains a net profit margin of 29.3%.
Carries low leverage with a debt-to-equity ratio of 0.13.
Recent Developments
- Mar 2026 Revenue of ₹2,187.19 Cr (+12.9% YoY); net profit ₹641.24 Cr.
- Trailing 12 Months Year-on-year growth — revenue +12.9%, earnings +19.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 24.1%, profit CAGR 31.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 24.12% |
| 1 Year: | 12.89% |
Compounded Profit Growth
| 5 Years: | 31.65% |
| 1 Year: | 19.57% |
Stock Price Performance
| 1 Year: | +31.02% |
| 6 Months: | +46.93% |
| 3 Months: | +53.98% |
| 1 Month: | +12.80% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)67.79 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 29.3%.
- Compounding revenue at 24.1% over 5 years.
- Profit CAGR of 31.6% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 389.00 Cr | 395.00 Cr | 410.00 Cr | 436.00 Cr | 453.00 Cr | 459.00 Cr | - | 492.96 Cr | 502.45 Cr | 510.22 Cr | 534.00 Cr | 542.77 Cr | 600.16 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | 195.35 Cr | 201.20 Cr | 195.24 Cr | - | 215.14 Cr | 245.00 Cr |
| Gross Profit | - | - | - | - | - | - | - | 297.61 Cr | 301.25 Cr | 314.98 Cr | - | 327.63 Cr | 355.16 Cr |
| Operating Expenses | 265.00 Cr | 269.00 Cr | 273.00 Cr | 293.00 Cr | 308.00 Cr | 307.00 Cr | - | 151.52 Cr | 150.23 Cr | 153.51 Cr | 345.00 Cr | 157.22 Cr | 169.72 Cr |
| Operating Income | 113.00 Cr | 116.00 Cr | 125.00 Cr | 128.00 Cr | 129.00 Cr | 136.00 Cr | - | 146.09 Cr | 151.02 Cr | 161.47 Cr | 171.00 Cr | 170.41 Cr | 185.44 Cr |
| EBITDA | 124.00 Cr | 127.00 Cr | 137.00 Cr | 142.00 Cr | 145.00 Cr | 152.00 Cr | - | 193.64 Cr | 193.88 Cr | 200.93 Cr | 189.00 Cr | 223.35 Cr | 232.60 Cr |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | - | 18.00 L | 17.00 L | 18.00 L | 0 | 18.00 L | 36.00 L |
| Pretax Income | 124.00 Cr | 127.00 Cr | 146.00 Cr | 145.00 Cr | 146.00 Cr | 154.00 Cr | - | 177.26 Cr | 176.67 Cr | 184.46 Cr | 201.00 Cr | 203.89 Cr | 213.44 Cr |
| Tax Provision | 22.32 Cr | 22.86 Cr | 29.20 Cr | 26.10 Cr | 24.82 Cr | 29.26 Cr | - | 37.19 Cr | 31.39 Cr | 33.70 Cr | 40.20 Cr | 38.03 Cr | 40.56 Cr |
| Net Income | 101.00 Cr | 104.00 Cr | 116.00 Cr | 120.00 Cr | 121.00 Cr | 125.00 Cr | - | 138.96 Cr | 142.57 Cr | 152.80 Cr | 160.00 Cr | 163.88 Cr | 170.11 Cr |
| Diluted EPS | 13.45 | 13.62 | 15.13 | 15.43 | 16.01 | 16.31 | - | 18.19 | 18.69 | 20.03 | 20.32 | 21.51 | 22.31 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 252.00 Cr | 239.00 Cr | 402.00 Cr | 540.00 Cr | 649.00 Cr | 863.00 Cr | 1,061.00 Cr | - | 1,453.82 Cr | 1,679.55 Cr | 1,937.47 Cr | 2,187.19 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 669.27 Cr | 729.34 Cr | 770.84 Cr | 865.68 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 784.55 Cr | 950.21 Cr | 1,166.63 Cr | 1,321.51 Cr |
| Operating Expenses | 192.00 Cr | 175.00 Cr | 276.00 Cr | 345.00 Cr | 417.00 Cr | 603.00 Cr | 732.00 Cr | - | 386.19 Cr | 449.28 Cr | 585.66 Cr | 633.43 Cr |
| Operating Income | 52.00 Cr | 57.00 Cr | 112.00 Cr | 176.00 Cr | 209.00 Cr | 228.00 Cr | 292.00 Cr | - | 398.36 Cr | 500.93 Cr | 580.97 Cr | 688.08 Cr |
| EBITDA | 60.00 Cr | 64.00 Cr | 125.00 Cr | 195.00 Cr | 232.00 Cr | 260.00 Cr | 329.00 Cr | - | 497.12 Cr | 618.65 Cr | 743.35 Cr | 876.43 Cr |
| Interest Expense | 1.00 Cr | 0 | 1.00 Cr | 1.00 Cr | 1.00 Cr | 0 | 2.00 Cr | - | 78.00 L | 78.00 L | 61.00 L | 87.00 L |
| Pretax Income | 53.00 Cr | 60.00 Cr | 121.00 Cr | 188.00 Cr | 227.00 Cr | 269.00 Cr | 314.00 Cr | - | 451.35 Cr | 564.43 Cr | 676.78 Cr | 802.79 Cr |
| Tax Provision | 12.19 Cr | 14.40 Cr | 25.41 Cr | 43.24 Cr | 49.94 Cr | 53.80 Cr | 62.80 Cr | - | 74.36 Cr | 103.01 Cr | 135.69 Cr | 153.06 Cr |
| Net Income | 41.00 Cr | 46.00 Cr | 96.00 Cr | 145.00 Cr | 177.00 Cr | 215.00 Cr | 251.00 Cr | - | 376.26 Cr | 457.09 Cr | 536.31 Cr | 641.24 Cr |
| Diluted EPS | 5.43 | 6.05 | 12.65 | 19.15 | 23.35 | 28.42 | 32.03 | - | 49.18 | 59.90 | 70.25 | 84.11 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 229.00 Cr | 267.00 Cr | 358.00 Cr | 500.00 Cr | 743.00 Cr | 1,126.00 Cr | 1,364.00 Cr | - | 2,191.40 Cr | 2,698.12 Cr | 3,207.85 Cr | 4,045.48 Cr |
| Current Assets | - | - | - | - | - | - | - | - | 1,552.19 Cr | 1,892.92 Cr | 2,133.95 Cr | 2,585.66 Cr |
| Cash & Equivalents | - | - | - | - | - | - | - | - | 484.47 Cr | 545.77 Cr | 583.20 Cr | 94.18 Cr |
| Inventory | - | - | - | - | - | - | - | - | 288.22 Cr | 363.04 Cr | 336.10 Cr | 428.86 Cr |
| Receivables | - | - | - | - | - | - | - | - | 394.06 Cr | 542.72 Cr | 632.49 Cr | 825.81 Cr |
| Total Liabilities | - | - | - | - | - | - | - | - | 284.13 Cr | 351.29 Cr | 321.46 Cr | 414.68 Cr |
| Current Liabilities | - | - | - | - | - | - | - | - | 268.00 Cr | 330.85 Cr | 305.99 Cr | 385.94 Cr |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Debt | 2.00 Cr | 2.00 Cr | 1.00 Cr | 1.00 Cr | 36.00 Cr | 113.00 Cr | 235.00 Cr | - | 5.48 Cr | 1.97 Cr | 5.02 Cr | 4.61 Cr |
| Total Equity | 93.00 Cr | 128.00 Cr | 225.00 Cr | 364.00 Cr | 597.00 Cr | 873.00 Cr | 969.00 Cr | - | 1,880.48 Cr | 2,315.71 Cr | 2,850.49 Cr | 3,586.42 Cr |
| Shares Outstanding | - | - | - | - | - | - | - | - | 7.59 Cr | 7.59 Cr | 7.60 Cr | 7.60 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 50.00 Cr | 42.00 Cr | 68.00 Cr | 66.00 Cr | 83.00 Cr | 45.00 Cr | 269.00 Cr | - | 271.37 Cr | 318.39 Cr | 432.37 Cr | 523.23 Cr |
| Investing Cash Flow | -23.00 Cr | -6.00 Cr | -36.00 Cr | -69.00 Cr | -100.00 Cr | -54.00 Cr | -30.00 Cr | - | -217.58 Cr | -320.04 Cr | -334.73 Cr | -582.29 Cr |
| Financing Cash Flow | -9.00 Cr | -14.00 Cr | -7.00 Cr | -12.00 Cr | 90.00 Cr | 80.00 Cr | -24.00 Cr | - | -28.17 Cr | -38.07 Cr | -38.32 Cr | -46.46 Cr |
| Capital Expenditure | -26.00 Cr | -8.00 Cr | -25.00 Cr | -48.00 Cr | -65.00 Cr | -77.00 Cr | -74.00 Cr | - | -193.47 Cr | -145.82 Cr | -191.52 Cr | -248.13 Cr |
| Free Cash Flow | 24.00 Cr | 34.00 Cr | 43.00 Cr | 18.00 Cr | 18.00 Cr | -32.00 Cr | 195.00 Cr | - | 77.90 Cr | 172.57 Cr | 240.85 Cr | 275.10 Cr |
| Net Change in Cash | 19.00 Cr | 23.00 Cr | 25.00 Cr | -14.00 Cr | 73.00 Cr | 70.00 Cr | 215.00 Cr | - | 25.62 Cr | -39.72 Cr | 59.32 Cr | -105.52 Cr |
Ratios (Annual)
Figures in %.
| Metric | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | 54.0% | 56.6% | 60.2% | 60.4% |
| Operating Margin % | 20.6% | 23.8% | 27.9% | 32.6% | 32.2% | 26.4% | 27.5% | - | 27.4% | 29.8% | 30.0% | 31.5% |
| Net Margin % | 16.3% | 19.2% | 23.9% | 26.9% | 27.3% | 24.9% | 23.7% | - | 25.9% | 27.2% | 27.7% | 29.3% |
| ROE % | 44.1% | 35.9% | 42.7% | 39.8% | 29.6% | 24.6% | 25.9% | - | 20.0% | 19.7% | 18.8% | 17.9% |
| ROCE % | - | - | - | - | - | - | - | - | 20.7% | 21.2% | 20.0% | 18.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CAPLIPOINT
CAPLIPOINT Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE1VY0VjRFBYXzZCWGtrbWNRNXhfdzNqSktNT09GLWFiLV9ha1EyLTJpamx2bFRjM245S0JuN1I2RkNYNmtpa1VQTmsyVUxjbHFDS09nTVVZMTNnTGRaaVA0QlVhclN6SFF5ZVFqd1ZwVFR5S1l0Z19XSjFaSjFHdw?oc=5" target="_blan…
Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Looks Like A Good Stock, And It's Going Ex-Dividend Soon - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi_gFBVV95cUxQd0pEMkoxSWJ3a1UzUWlCRmdBd1BLZ3FSdVF2dFI3V3FLXzJvR1I0TXdYU0cyQS1EMXFBR2U2a0VnZmx5QTh6aGxVZUpLTlZaamExMGVXYmV1YlhjcUg2LVl0TjZYRGNRMWdwYjA0LWVhTWpWVHVkWG1aSUxQTnpHRDV4RS01WWZ5LV91TG…
CAPLIPOINT: FY26 revenue up 13.2% and PAT up 20.1%, with robust cash reserves and no debt - TradingView
<a href="https://news.google.com/rss/articles/CBMi_AFBVV95cUxOR1I4RS1LdVo3T2NORUVBb2gtNi1zejIyUC1heFlqc20ybndJTnB4aW1XUVQtcmJOT0s0UGdVN2QzT2l5YWxJb0cxSW1QODFlN09CMGNrUjZJSFhLV0lSZWR4akRrYTlpbGdtLUpybEpKWDZPblFTMnNHbXBwQy1SOVpsOEYyTlcwMnFMb3…
Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi_gFBVV95cUxOZmVIa1cxOEYxWm9MREF2SW1NdmVzWkNRd0g1dF9VMXpydHEtUnNCdDNYb0QxZEJ1U3lVem9Ral9TYVpTU1pULTBUb3dfX082WjlrWUJTTDctb1JXRWg2VkMzZHFwTWJwbllJbGs0cnRJRWZ4NWdremgxT1F0ME1uQ2JxZGxSWmpCUzc3cU…
Caplin Point Laboratories Ltd. Share Price Live Today - CNBC TV18
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOMDZlTjFqMG01aWZfc1ZOTlRGLXhDdlJha3hxM3VsWGpORTd6djhmVVJjdF9WaGtJd0RsU0YwWlB1eENOUTJ4VmNpeEVGMTYwam1yYWlxVGJWeXNobmtuQXZfR3N4RmJxeG1fbVE4aXdBeEhtVjVLaFMwSTNEZXdVTHJES2R1SFN0WnZvV1…
Caplin Point Laboratories' (NSE:CAPLIPOINT) five-year earnings growth trails the strong shareholder returns - simplywall.st
<a href="https://news.google.com/rss/articles/CBMigAJBVV95cUxOMjJwRGpvYmJrMWdyY21GSkFFQUxZazNRem8wSVAtQVdkOG5rXzRiZDB1Y3R2RkdyM25VSWhvWkgtQWRuQlRHS3JFYWRYelpYZmlYcVlERE1nU0xoaThIbDhwX1FJVVJnU21yWHMwVGFGM25laG9sbDhhekNOenlKTHlDc2pVODB1Q0hyZz…
CAPLIPOINT — Frequently Asked Questions
What is the current share price of CAPLIPOINT?
As of 2026-07-15 09:52 IST, CAPLIPOINT trades at ₹2,667.20 on NSE. Its 52-week range is ₹1,501.83 to ₹2,667.20.
What is the market capitalisation of CAPLIPOINT?
CAPLIPOINT has a market capitalisation of ₹20,273.84 Cr on NSE.
What is the P/E ratio of CAPLIPOINT?
CAPLIPOINT trades at a trailing price-to-earnings (P/E) ratio of 31.71. Its price-to-book (P/B) ratio is 5.54.
What is the return on equity (ROE) of CAPLIPOINT?
CAPLIPOINT has a return on equity (ROE) of 17.88%. Its return on capital employed (ROCE) is 18.80%.
Is CAPLIPOINT a good stock to buy?
This page provides a data-driven analysis of CAPLIPOINT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.